Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • China rebukes west over military moves after close call in Taiwan Strait
    • Indonesia floats Ukraine peace plan, triggering sharp western criticism
    • Train crash in India kills more than 260 people
    • Saudi Arabia’s ‘prickly prince’ of oil bristles as crude price slides
    • Three Israeli soldiers shot dead on Egyptian border
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Boiler makers up in arms over UK heat pump targets
      • AI ripe to shake up private banking, says Israeli entrepreneur
      • UBS considers delaying results after Credit Suisse rescue deal
      • AstraZeneca defies geopolitics to bet on China
      • Asda’s owners recycle proceeds of earlier deal to fund EG takeover
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Saudi Arabia’s ‘prickly prince’ of oil bristles as crude price slides
      • Handful of tech stocks drive diverging measures of S&P 500 performance
      • Japan inflation will drive savers back to the stock market, says exchange chief
      • Wall Street prepares to take on established crypto companies
      • Active management is a sham — no wonder my returns are suspect
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Management 101: don’t drain a reservoir to find your phone
      • The frictionless life goes on
      • AI has given Palantir its mystique back
      • Jamie Dimon’s Shanghai show points to broader chill in China
      • Ukraine’s rapid reconstruction will be in Europe’s own interest
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • The dismal truth about email
      • Can a virtual PA turbocharge your career?
      • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Why motorcycle gangs will end with a whimper, not a rev
      • Cristiano Ronaldo vs Lionel Messi: who was the greatest footballer?
      • Trump or not, US meltdown could be inevitable
      • Sci-fi writer Ted Chiang: ‘The machines we have now are not conscious’
      • The American luxury lifestyle brand storming the Cotswolds
    • HTSI
    1. Companies
    2. Health
    • Healthcare
    • Pharmaceuticals
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Health

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Sunday, 4 June, 2023
      Supply chains
      US cancer drug shortage forces doctors to ration life-saving treatments

      Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected

      2 hours ago
    • Sunday, 4 June, 2023
      LexArtificial intelligence
      Mental health apps: the AI therapist cannot see you now Premium content

      Unsupervised generative AI could harm users and no one should risk their mental stability with ad hoc experimentation

    • Sunday, 4 June, 2023
      Travelista
      Best of the Balearics – new hotels to book now

      Chic openings on the Spanish archipelago

    • Saturday, 3 June, 2023
      ObituaryHarald zur Hausen
      Harald zur Hausen, virologist, 1936-2023

      Nobel Prize winner who discovered the cause of cervical cancer in humans

    • Friday, 2 June, 2023
      Cannabis industry
      UK medical cannabis group woos patients to buy into the business

      Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production

    • Friday, 2 June, 2023
      Health sector
      More than 400 Grail patients incorrectly told they may have cancer

      Error prompts life assurance customers to pause or review relationship with early detection biotech

    • Friday, 2 June, 2023
      David Strain
      Vaping as a cure for smoking has brought its own ills

      Marketing attractive nicotine products to children risks a whole generation’s health

    • Thursday, 1 June, 2023
      Genomics
      ‘Primate AI algorithm’ predicts genetic health risks

      Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans

    • Thursday, 1 June, 2023
      Helen Thomas
      PMI should forget wellness and focus on smokers who want to quit

      The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try

    • Thursday, 1 June, 2023
      Mariana Mazzucato
      Preparing for the next pandemic will take a global commitment

      The leaked draft of the WHO Pandemic Accord contains worrying signs

    • Thursday, 1 June, 2023
      Helen Thomas
      Ailing UK life sciences sector will need further treatment

      Policy prescriptions are plentiful but momentum and money behind them is lacking

    • Wednesday, 31 May, 2023
      News in-depthUS opioid epidemic
      ‘People rot from the inside out’: lethal xylazine deepens the US drug crisis

      Cartels are cutting fentanyl with the cheap sedative, driving a surge in overdoses in cities such as Philadelphia

    • Wednesday, 31 May, 2023
      Behind the Money podcast35 min listen
      Best Of: Inside Johnson & Johnson’s bankruptcy two-step

      Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?

    • Tuesday, 30 May, 2023
      Coronavirus
      China investigated Covid lab leak claims, says top scientist

      Health official’s admission undermines Beijing’s dismissals that virus could have emerged from Wuhan facility

    • Tuesday, 30 May, 2023
      News in-depthClimate Capital
      Pest control groups prepare for mosquito boom in rich countries as planet warms

      Rise in temperatures has led to the spread of disease-carriers to higher altitudes

    • Monday, 29 May, 2023
      HTSI
      The best summer road cycling gear

      This season’s performance-driven essentials

    • Friday, 26 May, 2023
      Covid-19 vaccines
      Brussels and Pfizer agree deal to cut supply of Covid vaccines

      Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes

    • Friday, 26 May, 2023
      Working ItWorking It: Mental Health and Wellbeing
      Employers see the positive side of ADHD and autism

      Recognition grows of the beneficial qualities of neurodiverse conditions

    • Thursday, 25 May, 2023
      Drug prices
      No ‘magic wand’ for financial pressures, Hunt tells pharma groups

      UK unveils reforms worth £650mn to boost the life sciences sector

    • Thursday, 25 May, 2023
      Jemima Kelly
      Why we should not be so anxious about anxiety

      Some psychologists think we talk about the emotion in the wrong way

    • Thursday, 25 May, 2023
      Special ReportAfrica’s Fastest Growing Companies
      Africa healthcare faces dialysis challenge

      Continent’s rising demographics present an opportunity for private providers

    • Wednesday, 24 May, 2023
      Biotech
      UK to announce funding boost for life sciences

      Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing

    • Wednesday, 24 May, 2023
      The FT ViewThe editorial board
      Investors can play their part in the war on superbugs

      As McDonald’s is targeted, governments also need to tighten and enforce rules

    • Wednesday, 24 May, 2023
      Medical science
      AI-based ‘digital bridge’ enables paraplegic patient to walk

      Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries

    • Wednesday, 24 May, 2023
      Aviva PLC
      Aviva’s private health cover sales jump 25% as NHS struggles with backlog

      Independent data shows record number of UK patients paying for treatment

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    The Role of Big Pharma in Consumer Healthcare
    How and why are spin-offs taking place and what are the market implications?
    Wednesday, 7th JuneOnline
    FT Live
    Transforming Approaches to Triple-Negative Breast Cancer
    Raising awareness, innovating treatments and improving patient support
    Thursday, 8th JuneOnline
    FT Live
    Clinical Data Management in Healthcare & Life Sciences Research
    Innovating and adapting as technology evolves
    Tuesday, 27th JuneOnline
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In